Global Infusion Therapy Market
Published Date:Jan 2026
Industry: Healthcare
Regions:
North America,
Europe,
Asia-Pacific,
Latin America,
Middle East & Africa
Format: PDF
Page: 200
Forecast Period: 2026-2033
Historical Range: 2020-2024
Global Infusion Therapy Market
size was valued at USD 29.7 billion in
2025 and is expected to reach at USD 54.6 billion in 2033, with a CAGR of 6.4% during the forecast
period of 2025 to 2033.
Global Infusion Therapy Market Overview
The global infusion therapy
market encompasses the delivery of fluids, medications, and nutrients directly
into the bloodstream through intravenous or other parenteral routes. It plays a
vital role in treating chronic and acute conditions such as cancer, diabetes,
gastrointestinal disorders, and immune deficiencies. Market growth is driven by
the rising burden of chronic diseases, an aging population, and increased use
of biologics and specialty drugs. Technological advancements in infusion
devices, along with the expanding adoption of home and ambulatory infusion
services, are further enhancing treatment efficiency, patient comfort, and
overall healthcare outcomes worldwide.
Global Infusion Therapy Market Scope
|
Global Infusion
Therapy Market |
|||
|
Years
Considered |
|||
|
Historical Period |
2020 - 2024 |
Market Size (2025) |
USD 29.7 Billion |
|
Base Year |
2025 |
Market Size
(2033) |
USD 54.6 Billion |
|
Forecast Period |
2026 - 2033 |
CAGR (2026 – 2033) |
6.4% |
|
Segments
Covered |
|||
|
By Product |
·
Infusion Pumps o Volumetric
Pumps o Syringe
Pumps o Patient-Controlled
Analgesia (PCA) Pumps o Ambulatory/Portable
Pumps o Enteral
Feeding Pumps ·
Infusion Consumables & Accessories o IV
Sets o IV
Catheters & Cannulas o Needleless
Connectors o Administration
Sets |
||
|
By Indicator |
·
Cancer ·
Gastrointestinal
Diseases/Disorders ·
Congestive
Heart Failure ·
Rheumatoid
Arthritis ·
Hemophilia ·
Immune
Deficiencies ·
Others |
||
|
By Therapy |
·
Antibiotic/Antiviral ·
Anti-coagulation ·
Anti-emetics ·
Blood Component Stimulating Factor ·
Chemotherapy ·
Nutrition ·
Hydration ·
Pain Management |
||
|
By Application |
·
Chemotherapy ·
Diabetes ·
Gastrointestinal
Diseases ·
Pain
Management ·
Others |
||
|
By End User |
·
Hospitals ·
Ambulatory Surgical Centers ·
Clinics ·
Homecare Settings |
||
|
Countries
Catered |
|||
|
North America |
·
United States ·
Canada ·
Mexico |
||
|
Europe |
·
United
Kingdom ·
Germany ·
France ·
Spain ·
Italy ·
Rest
of Europe |
||
|
Asia Pacific |
·
China ·
India ·
Japan ·
Australia ·
South Korea ·
Rest of Asia Pacific |
||
|
Latin America |
·
Brazil ·
Argentina ·
Rest
of Latin America |
||
|
Middle East & Africa
|
·
Saudi Arabia ·
South Africa ·
Rest of MEA |
||
|
Key Companies |
|||
Global Infusion Therapy Market Dynamics
The global infusion therapy
market dynamics are shaped by a combination of clinical demand, technological
innovation, and evolving healthcare delivery models. A major driver is the
increasing prevalence of chronic and life-threatening diseases such as cancer,
autoimmune disorders, diabetes, and cardiovascular conditions, which often
require long-term and precise drug administration through infusion therapy. The
growing geriatric population further accelerates demand, as older patients
typically require continuous and supportive infusion-based treatments. In
parallel, the rapid adoption of biologics, biosimilars, and specialty
drugs—many of which cannot be administered orally—has significantly expanded
the application scope of infusion therapy across therapeutic areas.
Technological advancements play a
critical role in market expansion, with the development of smart infusion
pumps, dose error reduction systems, and improved vascular access devices
enhancing patient safety and treatment accuracy. Additionally, healthcare
systems worldwide are increasingly shifting from hospital-based infusion toward
home and ambulatory infusion settings to reduce costs and improve patient
convenience. However, the market also faces restraints such as high treatment
and device costs, risk of infusion-related complications, and stringent
regulatory requirements governing infusion devices and drug administration.
Limited access to skilled healthcare professionals, particularly in emerging
economies, further challenges market growth.
Despite these constraints,
opportunities continue to emerge through digital health integration, remote
patient monitoring, and expanding healthcare infrastructure in developing
regions. Overall, the interplay between rising clinical demand, innovation, cost
pressures, and regulatory oversight defines the competitive and evolving
landscape of the global infusion therapy market.
Global Infusion Therapy Market
Segment Analysis
The global infusion therapy
market segment analysis highlights a diverse and well-structured landscape
driven by product innovation, expanding clinical applications, and evolving
care settings. By product, infusion pumps represent a significant share of the
market due to their critical role in accurate and controlled drug delivery.
Volumetric pumps are widely used in hospitals for continuous fluid
administration, while syringe pumps are preferred for low-volume and
high-precision drug delivery, particularly in neonatal and critical care.
Patient-controlled analgesia (PCA) pumps support effective pain management by
allowing patients to self-administer controlled doses, whereas ambulatory or
portable pumps are gaining traction with the growth of home infusion therapy.
Enteral feeding pumps are increasingly utilized for long-term nutritional
support. Infusion consumables and accessories, including IV sets, IV catheters
and cannulas, needleless connectors, and administration sets, form a recurring
revenue segment due to their high usage rates and single-use nature.
By indication, cancer remains a
dominant segment owing to the extensive use of chemotherapy, immunotherapy, and
supportive infusion treatments. Gastrointestinal diseases, congestive heart
failure, rheumatoid arthritis, hemophilia, and immune deficiencies also
contribute significantly, supported by the need for long-term and targeted
infusion therapies. In terms of therapy type, chemotherapy and antibiotic or
antiviral infusion therapies account for substantial demand, followed by
nutrition, hydration, pain management, anti-coagulation, anti-emetics, and
blood component stimulating factors, reflecting the broad therapeutic utility
of infusion therapy.
By application, chemotherapy
leads the market due to the rising global cancer burden, while diabetes,
gastrointestinal diseases, and pain management applications continue to expand
with improved infusion technologies. Other applications include critical care
and supportive therapies. By end user, hospitals hold the largest market share
due to advanced infrastructure and high patient inflow. However, ambulatory
surgical centers, clinics, and homecare settings are witnessing rapid growth,
driven by cost-efficiency, patient convenience, and the increasing shift toward
decentralized healthcare delivery models.
Global Infusion Therapy Market
Regional Analysis
The global infusion therapy
market exhibits varied growth patterns across regions, influenced by healthcare
infrastructure, disease prevalence, and adoption of advanced medical
technologies. North America dominates the market due to its well-established healthcare
system, high prevalence of chronic diseases, strong reimbursement frameworks,
and early adoption of advanced infusion devices and home infusion services.
Europe follows closely, supported by an aging population, increasing cancer
incidence, and favorable government initiatives promoting patient safety and
quality care. The Asia Pacific region is expected to witness the fastest
growth, driven by rising healthcare expenditure, expanding hospital networks,
growing awareness of infusion-based treatments, and a large patient pool in
countries such as China and India. Latin America shows steady growth owing to
improving healthcare infrastructure and increasing access to advanced
therapies. Meanwhile, the Middle East and Africa market is gradually expanding,
supported by healthcare investments, although growth remains constrained by
limited access to skilled professionals and advanced infusion technologies.
Global Infusion Therapy Market Key Players
·
Option Care Health Inc.
·
Baxter International Inc.
·
ICU Medical, Inc.
·
B. Braun Melsungen AG
·
Terumo Corporation
·
Moog Inc.
·
Fresenius SE & Co. KGaA
·
Smiths Medical
·
JMS Co. Ltd.
·
CareFusion Corporation
Recent Developments
In May 2025, KabaFusion,
a U.S. home and alternative site infusion therapy provider, acquired Infusion
Care assets from Coram®, adding six infusion pharmacies and ambulatory suites
and significantly expanding its reach across 26 states to serve more patients
with chronic and acute therapies.
In January 2026, The
National Home Infusion Association (NHIA) welcomed Inovalon to its Future
of Infusion Advisory Council, a collaboration aimed at using data analytics and
technology to address operational and clinical workflow challenges in home and
alternate site infusion care.
Research Methodology
At Foreclaro Global Research, our
research methodology is firmly rooted in a comprehensive and systematic
approach to market research. We leverage a blend of reliable public and
proprietary data sources, including industry reports, government publications,
company filings, trade journals, investor presentations, and credible online
databases. Our analysts critically evaluate and triangulate information to
ensure accuracy, consistency, and depth of insights. We follow a top-down and
bottom-up data modelling framework to estimate market sizes and forecasts,
supplemented by competitive benchmarking and trend analysis. Each research
output is tailored to client needs, backed by transparent data validation
practices, and continuously refined to reflect dynamic market conditions.
Table of Contents
Chapter 1. Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Regulatory Scenario
1.4. Executive Summary
Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Secondary Analyst Tools and Models
Chapter 3. Market Dynamics
3.1. Market
driver analysis
3.1.1. Growing
geriatric population requiring long-term and supportive care
3.1.2. Increasing
adoption of biologics and specialty drugs requiring infusion-based delivery
3.2. Market
restraint analysis
3.2.1. High
cost associated with infusion therapy equipment and specialty drugs
3.3. Market
Opportunity
3.3.1. Integration
of digital health and remote patient monitoring in infusion services
3.4. Market
Challenges
3.4.1. Stringent
regulatory requirements for infusion devices and drug administration
Chapter 4. Market Variables and Outlook
4.1. SWOT
Analysis
4.1.1. Strengths
4.1.2. Weaknesses
4.1.3. Opportunities
4.1.4. Threats
4.2. PESTEL
Analysis
4.2.1. Political
Landscape
4.2.2. Economic Landscape
4.2.3. Social
Landscape
4.2.4. Technological
Landscape
4.2.5. Environmental
Landscape
4.2.6. Legal
Landscape
4.3. Porter’s
Five Forces Analysis
4.3.1. Bargaining
Power of Suppliers
4.3.2. Bargaining
Power of Buyers
4.3.3. Threat
of Substitute
4.3.4. Threat
of New Entrant
4.3.5. Competitive
Rivalry
4.4. Value
Chain Analysis
4.5. Covid
Impact Analysis
Chapter 5. Infusion Therapy Market: Product Estimates
& Trend Analysis
5.1. Infusion
Therapy Market value share and forecast, (2020 to 2033)
5.2. Incremental
Growth Analysis and Infographic Presentation
5.3. Infusion
Pumps
5.3.1. Volumetric
Pumps
5.3.2. Syringe
Pumps
5.3.3. Patient-Controlled
Analgesia (PCA) Pumps
5.3.4. Ambulatory/Portable
Pumps
5.3.5. Enteral
Feeding Pumps
5.4. Infusion
Consumables & Accessories
5.4.1. IV
Sets
5.4.2. IV
Catheters & Cannulas
5.4.3. Needleless
Connectors
5.4.4. Administration
Sets
Chapter 6. Infusion Therapy Market: Indicator Estimates
& Trend Analysis
6.1. Infusion
Therapy Market value share and forecast, (2020 to 2033)
6.2. Incremental
Growth Analysis and Infographic Presentation
6.3. Cancer
6.4. Gastrointestinal
Diseases/Disorders
6.5. Congestive
Heart Failure
6.6. Rheumatoid
Arthritis
6.7. Hemophilia
6.8. Immune
Deficiencies
6.9. Others
Chapter 7. Infusion Therapy Market: Therapy Estimates
& Trend Analysis
7.1. Infusion
Therapy Market value share and forecast, (2020 to 2033)
7.2. Incremental
Growth Analysis and Infographic Presentation
7.3. Antibiotic/Antiviral
7.4. Anti-coagulation
7.5. Anti-emetics
7.6. Blood
Component Stimulating Factor
7.7. Chemotherapy
7.8. Nutrition
7.9. Hydration
7.10. Pain
Management
Chapter 8. Infusion Therapy Market: Application Estimates
& Trend Analysis
8.1. Infusion
Therapy Market value share and forecast, (2020 to 2033)
8.2. Incremental
Growth Analysis and Infographic Presentation
8.3. Chemotherapy
8.4. Diabetes
8.5. Gastrointestinal
Diseases
8.6. Pain
Management
8.7. Others
Chapter 9. Infusion Therapy Market: End User Estimates
& Trend Analysis
9.1. Infusion
Therapy Market value share and forecast, (2020 to 2033)
9.2. Incremental
Growth Analysis and Infographic Presentation
9.3. Hospitals
9.4. Ambulatory
Surgical Centers
9.5. Clinics
9.6. Homecare
Settings
Chapter 10. Infusion Therapy Market: Regional Estimates
& Trend Analysis
10.1. Infusion
Therapy Market value share and forecast, (2020 to 2033)
10.2. Incremental
Growth Analysis and Infographic Presentation
10.3. North
America
10.4. Europe
10.5. Asia
Pacific
10.6. Middle
East & Africa
10.7. Latin
America
Chapter 11. Infusion Therapy Market: Country Estimates
& Trend Analysis
11.1. Infusion
Therapy Market value share and forecast, (2020 to 2033)
11.2. Incremental
Growth Analysis and Infographic Presentation
11.3. United
States
11.4. Canada
11.5. Mexico
11.6. United
Kingdom
11.7. France
11.8. Germany
11.9. Italy
11.10. Spain
11.11. China
11.12. India
11.13. Japan
11.14. South
Korea
11.15. Australia
11.16. Brazil
11.17. Argentina
11.18. Saudi
Arabia
11.19. South
Africa
Chapter 12. Competitive Landscape
12.1. Company
Market Share Analysis
12.2. Vendor
Landscape
12.3. Competition
Dashboard
Chapter 13. Company Profiles
13.1. Option
Care Health Inc.
13.1.1. Company
Overview
13.1.2. Financial
Details
13.1.3. Product
Analysis
13.1.4. Recent
Developments
13.2. Baxter
International Inc.
13.2.1. Company
Overview
13.2.2. Financial
Details
13.2.3. Product
Analysis
13.2.4. Recent
Developments
13.3. ICU
Medical, Inc.
13.3.1. Company
Overview
13.3.2. Financial
Details
13.3.3. Product
Analysis
13.3.4. Recent
Developments
13.4. B.
Braun Melsungen AG
13.4.1. Company
Overview
13.4.2. Financial
Details
13.4.3. Product
Analysis
13.4.4. Recent
Developments
13.5. Terumo
Corporation
13.5.1. Company
Overview
13.5.2. Financial
Details
13.5.3. Product
Analysis
13.5.4. Recent
Developments
13.6. Moog
Inc.
13.6.1. Company
Overview
13.6.2. Financial
Details
13.6.3. Product
Analysis
13.6.4. Recent
Developments
13.7. Fresenius
SE & Co. KGaA
13.7.1. Company
Overview
13.7.2. Financial
Details
13.7.3. Product
Analysis
13.7.4. Recent
Developments
13.8. Smiths
Medical
13.8.1. Company
Overview
13.8.2. Financial
Details
13.8.3. Product
Analysis
13.8.4. Recent
Developments
13.9. JMS
Co. Ltd.
13.9.1. Company
Overview
13.9.2. Financial
Details
13.9.3. Product
Analysis
13.9.4. Recent
Developments
13.10. CareFusion
Corporation
13.10.1.
Company Overview
13.10.2.
Financial Details
13.10.3.
Product Analysis
13.10.4.
Recent Developments
Segmentation
Infusion
Therapy Market, Product Outlook (Revenue - USD Million, 2020 - 2033)
Infusion
Pumps
·
Volumetric
Pumps
·
Syringe
Pumps
·
Patient-Controlled
Analgesia (PCA) Pumps
·
Ambulatory/Portable
Pumps
·
Enteral
Feeding Pumps
Infusion
Consumables & Accessories
·
IV
Sets
·
IV
Catheters & Cannulas
·
Needleless
Connectors
·
Administration
Sets
Infusion
Therapy Market, Indication Outlook (Revenue - USD Million, 2020 - 2033)
Cancer
Gastrointestinal
Diseases/Disorders
Congestive
Heart Failure
Rheumatoid
Arthritis
Hemophilia
Immune
Deficiencies
Others
Infusion
Therapy Market, Therapy Outlook (Revenue - USD Million, 2020 - 2033)
Antibiotic/Antiviral
Anti-coagulation
Anti-emetics
Blood
Component Stimulating Factor
Chemotherapy
Nutrition
Hydration
Pain
Management
Infusion
Therapy Market, Application Outlook (Revenue - USD Million, 2020 - 2033)
Chemotherapy
Diabetes
Gastrointestinal
Diseases
Pain
Management
Others
Infusion
Therapy Market, End user Outlook (Revenue - USD Million, 2020 - 2033)
Hospitals
Ambulatory
Surgical Centers
Clinics
Homecare
Settings
Infusion
Therapy Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)
North
America
Europe
Asia
Pacific
Latin
America
Middle East
& Africa
Methodology
Review our research methodology and quality standards for details about source selection, validation, forecasting, and review.
At Foreclaro Global Research, our research methodology is built to deliver clear, data-backed intelligence that supports confident decision-making. By combining rigorous secondary research, primary validations, and advanced forecasting models, we produce insights that are not only reliable but also strategically relevant for our clients.
1. Defining the Research Framework
Every study begins with a clear understanding of our client’s goals. We establish the market scope, define critical variables, and build a research framework tailored to the specific project. This upfront clarity ensures that our findings are sharply aligned with the strategic questions being addressed.
2. Robust Data Collection
Our analysts extract high-integrity data from a broad mix of credible sources including government databases, annual reports, regulatory filings, trade publications, scientific journals, and trusted industry portals. This secondary research is then supported with targeted primary inputs through interviews with key industry stakeholders—such as executives, subject matter experts, and channel partners—to capture real-world insights and contextual depth.
3. Advanced Forecasting and Modeling
To estimate market size and growth, we employ a hybrid of top-down and bottom-up modeling techniques. Our analysts apply proven forecasting models using historical data trends, economic indicators, technology adoption rates, and demand patterns. Sensitivity analysis and scenario modeling (base, optimistic, conservative) are incorporated to account for market volatility and uncertainty.
4. Data Triangulation and Validation
Accuracy is non-negotiable. We cross-validate every data point by triangulating it across three dimensions: source credibility, numerical consistency, and contextual alignment. This ensures our insights are not just statistically correct but strategically dependable. Discrepancies are resolved using subject expertise and multi-perspective reviews to deliver a balanced, unbiased analysis.
5. Quality Assurance and Final Review
Before delivery, each report undergoes a stringent quality assurance process. Our research output is reviewed for structure, clarity, consistency, and compliance with global standards. The final deliverable is tailored for decision-makers, whether it's a comprehensive industry report, data dashboard, or strategic presentation.
Why Our Methodology Works
What sets us apart is our adaptive data architecture and our commitment to analytical clarity. Every study is built with flexibility to accommodate dynamic markets, while our team blends quantitative rigor with domain-specific expertise. This allows us to deliver research that goes beyond information, we deliver intelligence that leads to action.
Support Questions
What is the current and forecasted size of the global infusion therapy market??
The global infusion therapy market was valued at approximately USD 29.7 billion in 2025 and is projected to grow significantly over the forecast period, reaching over USD 54 billion by 2033, driven by rising demand for advanced therapeutic delivery solutions.
Which factors are driving growth in the infusion therapy market worldwide??
What are the major segments within the infusion therapy market??
Which regions are leading the infusion therapy market and why??
What are the primary challenges or limitations impacting infusion therapy adoption??